Save Comparison | ![]() Magenta Therapeutics Magenta’s mission is to revolutionize stem cell transplant as the treatment for immune and blood diseases. | ![]() EpiVax EpiVax has developed comprehensive analytical capabilities in the field of computational immunology. | ![]() Transgene Transgene SA is a biopharmaceutical company. The Company designs and develops immunotherapy products to treat cancer and infectious diseases. | ![]() DBV Technologies We are committed to finding a safe, effective and patient-friendly therapy for food and pediatric allergy patients, for whom there are no currently approved treatments. |
Founding Date | Founding Date 2016 | Founding Date 1998 | Founding Date N/A | Founding Date 2002 |
Type | Type Public | Type Private | Type Public | Type Public |
Tags | ||||
Locations | Locations Cambridge, US HQ | Locations Providence, US HQ | Locations Illkirch, FR HQ Shanghai, CN Lyon, FR Boston, US | Locations Montrouge, FR HQ Bagneux, FR New York, US Summit, US |
Employees | Employees 72 | Employees 343% increase | Employees 1392% increase | Employees 311 |
Twitter followers | Twitter followers 2.2 k | Twitter followers 380 | Twitter followers 1.4 k | Twitter followers 1.5 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 3 | Number of tweets (last 30 days) 3 | Number of tweets (last 30 days) 5 | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 7.7 | Average likes per tweet (last 30 days) 0.3 | Average likes per tweet (last 30 days) 2.2 | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 33.33% | Percentage of tweets with engagement (last 30 days) 60% | Percentage of tweets with engagement (last 30 days) N/A |
Alexa Website Rank | Alexa Website Rank 413299 | Alexa Website Rank 361738 | Alexa Website Rank 221574 | Alexa Website Rank 292854 |
Employee Rating | Employee Rating N/A | Employee Rating 3.9 | Employee Rating 4.4 | Employee Rating 3.4 |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) €13.1m (FY, 2019) |
Net income | Net income ($76.8m) (FY, 2019) | Net income N/A | Net income N/A | Net income (€153.6m) (FY, 2019) |
Funding | ||||
Total funding raised | Total funding raised $ 150.5m | Total funding raised $ 3.2m | Total funding raised N/A | Total funding raised $ 28.2m |
EpiVax has developed comprehensive analytical capabilities in the field of computational immunology.
View companyTransgene SA is a biopharmaceutical company. The Company designs and develops immunotherapy products to treat cancer and infectious diseases.
View companyWe are committed to finding a safe, effective and patient-friendly therapy for food and pediatric allergy patients, for whom there are no currently approved treatments.
View company